메뉴 건너뛰기




Volumn 79, Issue 6, 2006, Pages 811-824

Multisubstituted olefins: Platform synthesis and applications to materials science and pharmaceutical chemistry

Author keywords

[No Author keywords available]

Indexed keywords

PHARMACEUTICAL CHEMISTRY; TAMOXIFEN;

EID: 33750591065     PISSN: 00092673     EISSN: 13480634     Source Type: Journal    
DOI: 10.1246/bcsj.79.811     Document Type: Article
Times cited : (78)

References (120)
  • 4
    • 0034678033 scopus 로고    scopus 로고
    • Diversity-oriented synthesis: a) S. L. Schreiber, Science 2000, 287, 1964.
    • (2000) Science , vol.287 , pp. 1964
    • Schreiber, S.L.1
  • 21
    • 0003535745 scopus 로고    scopus 로고
    • ed. by N. Miyaura, Springer, New York
    • b) Cross-Coupling Reactions, ed. by N. Miyaura, Springer, New York, 2002.
    • (2002) Cross-Coupling Reactions
  • 33
    • 0034829932 scopus 로고    scopus 로고
    • Selected examples of the use of the 2-pyridylsilyl group as a removable directing group: a) K. Itami, T. Koike, J. Yoshida, J. Am. Chem. Soc. 2001, 123, 6957.
    • (2001) J. Am. Chem. Soc. , vol.123 , pp. 6957
    • Itami, K.1    Koike, T.2    Yoshida, J.3
  • 40
    • 15044345663 scopus 로고    scopus 로고
    • A review on chelation-controlled Mizoroki-Heck reactions: M. Oestreich, Eur. J. Org. Chem. 2005, 783.
    • (2005) Eur. J. Org. Chem. , pp. 783
    • Oestreich, M.1
  • 41
    • 33750583353 scopus 로고    scopus 로고
    • note
    • Dimethyl(2-pyridyl)vinylsilane (1a) is now commercially available from Tokyo Kasei Kogyo Co., Ltd (TCI). Catalog Number: D2935.
  • 49
    • 84988124945 scopus 로고
    • Reviews on Hiyama-type silicon-based cross-coupling reaction: a) Y. Hatanaka, T. Hiyama, Synlett 1991, 845.
    • (1991) Synlett , pp. 845
    • Hatanaka, Y.1    Hiyama, T.2
  • 116
    • 33750592526 scopus 로고    scopus 로고
    • Celltech Therapeutics LTD, U.S. Patent 5608070
    • a) Celltech Therapeutics LTD, U.S. Patent 5608070.
  • 117
    • 33750583814 scopus 로고    scopus 로고
    • Celltech Therapeutics LTD, U.S. Patent 622977
    • b) Celltech Therapeutics LTD, U.S. Patent 622977.
  • 120
    • 33750583196 scopus 로고    scopus 로고
    • note
    • For applications of platform synthesis to the construction of pyrimidine-core extended π-systems, see Ref. 31.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.